Immunology and Biotherapies
40.0K views | +0 today
Follow
Immunology and Biotherapies
Page Ressources et Actualités du DIU immunologie et biothérapies
Your new post is loading...
Your new post is loading...
Scooped by Gilbert C FAURE
July 24, 2012 4:24 AM
Scoop.it!

New stem cell therapy succesfully rejuvenates aging heart muscle cells in humans

New stem cell therapy succesfully rejuvenates aging heart muscle cells in humans | Immunology and Biotherapies | Scoop.it
Damaged and aged heart tissue of older heart failure patients was rejuvenated by stem cells modified by scientists, according to research presented at the Ameri (RT @AGE: New stem cell therapy succesfully rejuvenates aging heart muscle cells in humans.)...
No comment yet.
Scooped by Gilbert C FAURE
July 23, 2012 1:43 PM
Scoop.it!

A Phase I Trial Of The Humanized Anti-GD2 Antibody In Children And Adolescents With Neuroblastoma, Osteosarcoma Or Melanoma | Clinical Trials News Digest

A Phase I Trial Of The Humanized Anti-GD2 Antibody In Children And Adolescents With Neuroblastoma, Osteosarcoma Or Melanoma | Clinical Trials News Digest | Immunology and Biotherapies | Scoop.it
Conditions :   Neuroblastoma;   Melanoma;   Osteosarcoma Intervention :   Biological: Anti-G2 antibody Sponsors :   St. Jude Children's Research Hospital;   St. Jude Children's Research Hospital;   Evan T. J. Dunbar Neuroblastoma Foundation, Inc.;...
No comment yet.
Scooped by Gilbert C FAURE
July 21, 2012 11:08 AM
Scoop.it!

Tips for Translational Cell Therapy Research [audio] | Eureka

Tips for Translational Cell Therapy Research [audio] | Eureka | Immunology and Biotherapies | Scoop.it
In this Eureka Podcast Episode, Shawna Jackman, Senior Research Scientist at Charles River, provides her top 10 tips to consider when designing a translational cell therapy preclinical program.
No comment yet.
Scooped by Gilbert C FAURE
July 20, 2012 3:36 PM
Scoop.it!

Sanofi and Regeneron Launch Comprehensive Phase 3 Clinical Program With LDL Cholesterol-Lowering PCSK9 Antibody - Drugs.com MedNews

Sanofi and Regeneron Launch Comprehensive Phase 3 Clinical Program With LDL Cholesterol-Lowering PCSK9 Antibody - Drugs.com MedNews | Immunology and Biotherapies | Scoop.it
ODYSSEY, a global program to evaluate SAR236553 REGN727, a potential first-in-class PCSK9 inhibitor, will comprise over ten clinical trials and will include mor (Sanofi and Regeneron Launch Comprehensive Phase 3 Clinical Program With LDL Cholesterol-Lowering...
No comment yet.
Scooped by Gilbert C FAURE
July 20, 2012 3:30 PM
Scoop.it!

Decitabine as Maintenance Therapy After Standard Therapy in Treating Patients With Previously Untreated Acute Myeloid Leukemia - Full Text View - ClinicalTrials.gov

Decitabine as Maintenance Therapy After Standard Therapy in Treating Patients With Previously Untreated Acute My...
No comment yet.
Scooped by Gilbert C FAURE
July 20, 2012 3:29 PM
Scoop.it!

American Society of Gene & Cell Therapy Online Journal Now Linked… - Pharma - eWallstreeter

American Society of Gene & Cell Therapy Online Journal Now Linked… - Pharma - eWallstreeter | Immunology and Biotherapies | Scoop.it
American Society of Gene & Cell Therapy Online Journal Now Linked… http://t.co/aZ0HspA9...
No comment yet.
Scooped by Gilbert C FAURE
July 20, 2012 11:56 AM
Scoop.it!

Genetically Engineered Lymphocyte Therapy After Peripheral Blood Stem Cell Transplant in Treating Patients With High-Risk, Intermediate-Grade, B-cell Non-Hodgkin Lymphoma - Full Text View - Clinica...

T-cell therapy with Transplant in Treating High-Risk, Intermediate-Grade, B-cell Non-Hodgkin Lymphoma - CITY OF HOPE http://t.co/6sbVbYD5...
No comment yet.
Scooped by Gilbert C FAURE
July 19, 2012 3:53 PM
Scoop.it!

Cell Therapy Blog: Late-stage industry-sponsored cell therapy trials

Cell Therapy Blog: Late-stage industry-sponsored cell therapy trials | Immunology and Biotherapies | Scoop.it
RT @celltherapy: We are tracking 47 industry-sponsored pivotal, ph 3 or 2/3 cell therapy trials involving >11,000 patients http://t.co/tu1F6yxu...
No comment yet.
Scooped by Gilbert C FAURE
July 19, 2012 11:57 AM
Scoop.it!

Nanoscale scaffolds and stem cells show promise in cartilage repair ...

Nanoscale scaffolds and stem cells show promise in cartilage repair ... | Immunology and Biotherapies | Scoop.it
Johns Hopkins tissue engineers have used tiny, artificial fiber scaffolds thousands of times smaller than a human hair to help coax stem cells into developing into cartilage, the shock-absorbing lining of elbows and knees that ...
No comment yet.
Scooped by Gilbert C FAURE
July 19, 2012 11:53 AM
Scoop.it!

PAX8 Mouse Monoclonal Antibody [BC12] Recognizes a Restricted ...

PAX8 Mouse Monoclonal Antibody [BC12] Recognizes a Restricted Epitope and Is Highly Sensitive in Renal Cell and Ovarian Cancers But Does Not Cross-react With B Cells and Tumors of Pancreatic Origin.
No comment yet.
Scooped by Gilbert C FAURE
July 18, 2012 1:17 PM
Scoop.it!

Antibody development in the next 5 years

Antibody development in the next 5 years | Immunology and Biotherapies | Scoop.it
How valuable would knowing your peers views on how antibody therapeutics are going to develop over the next 5 years be to you?
No comment yet.
Scooped by Gilbert C FAURE
July 18, 2012 10:48 AM
Scoop.it!

Nano Patents and Innovations: Nanoscale Scaffolds And Stem Cells ...

Nano Patents and Innovations: Nanoscale Scaffolds And Stem Cells ... | Immunology and Biotherapies | Scoop.it
Johns Hopkins tissue engineers have used tiny, artificial fiber scaffolds thousands of times smaller than a human hair to help coax stem cells into developing into cartilage, the shock-absorbing lining of elbows and knees that ...
No comment yet.
Scooped by Marcelo de Carvalho Bittencourt
July 18, 2012 10:28 AM
Scoop.it!

OMICS - BLOG | Dirty' Wild Mice May Be More Relevant Immunology Model » OMICS - BLOG

OMICS : This is the updated version of OMICS Blog which provide you detail description about the latest Journals | Conferences.
No comment yet.
Scooped by Gilbert C FAURE
July 23, 2012 1:44 PM
Scoop.it!

Antibody therapy may stabilize early Alzheimer’s symptoms > Facts & Fears > ACSH

Antibody therapy may stabilize early Alzheimer’s symptoms > Facts & Fears > ACSH via @rosie_ms: Antibody therapy may...
No comment yet.
Scooped by Gilbert C FAURE
July 23, 2012 7:19 AM
Scoop.it!

CYDY - Promising Antibody Technology for the Treatment of HIV/FIV

CYDY - Promising Antibody Technology for the Treatment of HIV/FIV | Immunology and Biotherapies | Scoop.it
CytoDyn (Other OTC:CYDY.PK - News) is a development stage biotech company focused on the discovery and development of novel anti-HIV and anti-FIV agents. The Company holds two proprietary platform technologies: Cytolin, a ...
No comment yet.
Scooped by Gilbert C FAURE
July 20, 2012 3:37 PM
Scoop.it!

Biotest’s Antibody-drug Conjugate BT-062 In Multiple Myeloma Combination Therapy

Biotest’s Antibody-drug Conjugate BT-062 In Multiple Myeloma Combination Therapy | Immunology and Biotherapies | Scoop.it
Biotest’s Antibody-drug Conjugate BT-062 In Multiple Myeloma Combination Therapy (#clinicaltrials Biotest’s Antibody-drug Conjugate BT-062 In Multiple Myeloma Combination Therapy: BT-062, an ant...)...
No comment yet.
Scooped by Gilbert C FAURE
July 20, 2012 3:35 PM
Scoop.it!

Free Article: Intraspinal Stem Cell Transplantation

Free Article: Intraspinal Stem Cell Transplantation | Immunology and Biotherapies | Scoop.it
Background: No United States-based clinical trials have attempted delivery of biological therapies directly to the spinal cord for treatment of amyotrophic lateral sclerosis (ALS) because of the lack of a meaningful US Food and Drug...
No comment yet.
Scooped by Gilbert C FAURE
July 20, 2012 3:30 PM
Scoop.it!

Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy - Full Text View - ClinicalTrials.gov

Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Prev...
No comment yet.
Scooped by Gilbert C FAURE
July 20, 2012 11:58 AM
Scoop.it!

Gefitinib Enhances Cytotoxicities of Antimicrotubule Agents... : Journal of Thoracic Oncology

Gefitinib Enhances Cytotoxicities of Antimicrotubule Agents... : Journal of Thoracic Oncology | Immunology and Biotherapies | Scoop.it
Introductions: Although randomized clinical trials showed no benefit from combining epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) with standard chemotherapy for advanced non–small-cell lung cancer (NSCLC), better results...
No comment yet.
Scooped by Gilbert C FAURE
July 19, 2012 3:54 PM
Scoop.it!

Anti–Interleukin-17 Monoclonal Antibody Ixekizumab in Psoriasis — NEJM

Anti–Interleukin-17 Monoclonal Antibody Ixekizumab in Psoriasis — NEJM | Immunology and Biotherapies | Scoop.it
Correspondence from The New England Journal of Medicine — Anti–Interleukin-17 Monoclonal Antibody Ixekizumab in Psoriasis (RT @JuanCIvancevich: Anti–Interleukin-17 Monoclonal Antibody Ixekizumab in Psoriasis — NEJM
No comment yet.
Scooped by Gilbert C FAURE
July 19, 2012 12:01 PM
Scoop.it!

Redirecting T Cells to Fight Cancer - Penn Medicine News Blog

Redirecting T Cells to Fight Cancer - Penn Medicine News Blog | Immunology and Biotherapies | Scoop.it
Penn Medicine is building a war chest of approaches to enhance the ability of T cells to attack as many cancer types as possible.
No comment yet.
Scooped by Gilbert C FAURE
July 19, 2012 11:55 AM
Scoop.it!

Killer T cell attacking cancer

Cambridge University's Under the Microscope is a collection of videos that show glimpses of the natural and man-made world in stunning close-up.
No comment yet.
Scooped by Gilbert C FAURE
July 19, 2012 11:53 AM
Scoop.it!

Actinium Pharmaceuticals Successfully Completes First Cohort in ...

Actimab-A™ treatment consists of the isotope Actinium 225 attached to the anti-CD33 monoclonal antibody lintuzumab (HuM195). “As we continue to achieve our stated milestones, completion of the first cohort brought us ...
No comment yet.
Scooped by Gilbert C FAURE
July 18, 2012 10:48 AM
Scoop.it!

Stem Cells Repair Damaged Spinal Cord Tissue - Physics Inventions

Stem Cells Repair Damaged Spinal Cord Tissue - Physics Inventions | Immunology and Biotherapies | Scoop.it
Researchers at Karolinska Institutet have shown how stem cells, together with other cells, repair damaged tissue in the mouse spinal cord. The results are of potential significance to the development of therapies for spinal cord ...
No comment yet.
Scooped by Marcelo de Carvalho Bittencourt
July 18, 2012 10:31 AM
Scoop.it!

Innovating immunology: an interview with Ruslan Medzhitov

Innovating immunology: an interview with Ruslan Medzhitov | Immunology and Biotherapies | Scoop.it
Innovating immunology: an interview with Ruslan Medzhitov http://t.co/ggSBqtpn...
No comment yet.